Amarin: The FDA Approves Vascepa for Lowering Cardiovascular Risk

From Amarin
Amarin (AMRN) announced the U.S. FDA has approved a new indication and label expansion for Vascepa® (icosapent ethyl) capsules. According to Amarin’s press release, with this label expansion approval, Vascepa has become . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.